# Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)

> **NCT02688803** · PHASE4 · TERMINATED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 2 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Dose dense AC-P
- **DRUG:** Dose dense AC
- **DRUG:** FEC-D

## Key facts

- **NCT ID:** NCT02688803
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08-30
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The study did not meet the pilot feasibility endpoints and was formally closed to accrual prematurely on February 8, 2017.
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02688803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02688803, "Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02688803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*